GSE207514,GSE207515 2 V 3 ACETYLCYSTEINE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207514,GSE207515 2 V 3 ACETYLCYSTEINE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207514,GSE207515 2 V 3 ACETYLCYSTEINE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207514,GSE207515 2 V 3 ACETYLCYSTEINE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207514,GSE207515 2 V 3 ACETYLCYSTEINE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H3 clustered histone 7

Gene

ATPase H+ transporting V1 subunit G2

Gene

thymosin beta 15C

Gene

nuclear pore complex interacting protein family member A9

Gene

Jrk helix-turn-helix protein

Gene

gamma-glutamyltransferase 5

Gene

neural EGFL like 1

Gene

synaptogyrin 1

Gene

transient receptor potential cation channel subfamily V member 1

Gene

kelch domain containing 7A

  • Gene

    H3 clustered histone 7


  • Gene

    ATPase H+ transporting V1 subunit G2


  • Gene

    thymosin beta 15C


  • Gene

    nuclear pore complex interacting protein family member A9


  • Gene

    Jrk helix-turn-helix protein


  • Gene

    gamma-glutamyltransferase 5


  • Gene

    neural EGFL like 1



  • Gene

    transient receptor potential cation channel subfamily V member 1


  • Gene

    kelch domain containing 7A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.